Presentation is loading. Please wait.

Presentation is loading. Please wait.

Biologic Therapy and Novel Molecular Targets of Severe Asthma

Published byMikael Bergström Modified over 6 years ago

Similar presentations

Presentation on theme: "Biologic Therapy and Novel Molecular Targets of Severe Asthma"— Presentation transcript:

1 Biologic Therapy and Novel Molecular Targets of Severe Asthma
Amber N. Pepper, MD, Harald Renz, MD, Thomas B. Casale, MD, Holger Garn, PhD  The Journal of Allergy and Clinical Immunology: In Practice  Volume 5, Issue 4, Pages (July 2017) DOI: /j.jaip Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Figure 1 Biologic and novel therapies for the treatment of severe asthma. This figure includes only approved and emerging therapies with published human data. CRTH2, Chemoattractant receptor-homologous molecule expressed on TH2 cells; DP2, prostaglandin D2 receptor 2; IgE, immunoglobulin E; IL, interleukin; TSLP, thymic stromal lymphopoeitin. The Journal of Allergy and Clinical Immunology: In Practice 2017 5, DOI: ( /j.jaip ) Copyright © 2017 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "Biologic Therapy and Novel Molecular Targets of Severe Asthma"

Similar presentations

Complementary and Alternative Medicine Use among Allergy Practices: Results of a Nationwide Survey of Allergists  Michael H. Land, MD, Julie Wang, MD 

Complementary and Alternative Medicine Use among Allergy Practices: Results of a Nationwide Survey of Allergists  Michael H. Land, MD, Julie Wang, MD 
The Relationship Between a Specific IgE Level and Asthma Outcomes: Results from the 2005-2006 National Health and Nutrition Examination Survey  Whitney.

The Relationship Between a Specific IgE Level and Asthma Outcomes: Results from the National Health and Nutrition Examination Survey  Whitney.
Advances in Diagnosing Peanut Allergy

Advances in Diagnosing Peanut Allergy
Rohit K. Katial, MD, Greg W. Bensch, MD, William W

Rohit K. Katial, MD, Greg W. Bensch, MD, William W
Endotype-driven care pathways in patients with chronic rhinosinusitis

Endotype-driven care pathways in patients with chronic rhinosinusitis
Aleena Banerji, MD, Kimberly G. Blumenthal, MD, MSc, Kenneth H

Aleena Banerji, MD, Kimberly G. Blumenthal, MD, MSc, Kenneth H
The Natural History of Food Allergy

The Natural History of Food Allergy
Vitamin D Insufficiency and Asthma in a US Nationwide Study

Vitamin D Insufficiency and Asthma in a US Nationwide Study
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Luciana Kase Tanno, MD, PhD, Moises A

Luciana Kase Tanno, MD, PhD, Moises A
Carboplatin-, Oxaliplatin-, and Cisplatin–specific IgE: Cross-reactivity and Value in the Diagnosis of Carboplatin and Oxaliplatin Allergy  Joana Caiado,

Carboplatin-, Oxaliplatin-, and Cisplatin–specific IgE: Cross-reactivity and Value in the Diagnosis of Carboplatin and Oxaliplatin Allergy  Joana Caiado,
Chronic rhinosinusitis: Potential new use for topical sulfasalazine

Chronic rhinosinusitis: Potential new use for topical sulfasalazine
Complementary and Alternative Medicine in Allergy-Immunology: More Information is Needed  Leonard Bielory, MD  The Journal of Allergy and Clinical Immunology:

Complementary and Alternative Medicine in Allergy-Immunology: More Information is Needed  Leonard Bielory, MD  The Journal of Allergy and Clinical Immunology:
Wells Syndrome with Bullous Lesions

Wells Syndrome with Bullous Lesions
Fanny Legrand, PhD, PharmD, Amy D. Klion, MD 

Fanny Legrand, PhD, PharmD, Amy D. Klion, MD 
Dennis K. Ledford, MD, Sally Wenzel, MD 

Dennis K. Ledford, MD, Sally Wenzel, MD 
Shyam Joshi, MD, David A. Khan, MD 

Shyam Joshi, MD, David A. Khan, MD 
Management of Hypersensitivity Reactions to Carboplatin and Paclitaxel in an Outpatient Oncology Infusion Center: A 5-Year Review  Aleena Banerji, MD,

Management of Hypersensitivity Reactions to Carboplatin and Paclitaxel in an Outpatient Oncology Infusion Center: A 5-Year Review  Aleena Banerji, MD,
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?
Desensitization to Chemotherapeutic Agents

Desensitization to Chemotherapeutic Agents

Similar presentations

Ads by Google